Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00415-019-09389-8.

Title:
NFL is a marker of treatment response in children with SMA treated with nusinersen | Journal of Neurology
Description:
Recently, the anti-sense oligonucleotide drug nusinersen was approved for spinal muscular atrophy (SMA) and our aim was to find a response marker for this treatment. Twelve children with SMA type 1 and two copies of the SMN2 gene were included in a consecutive single-center study. The children were sampled for CSF at baseline and every time nusinersen was given intrathecally. The neuronal biomarkers NFL and tau and the glial biomarker GFAP were measured. Motor function was assessed using CHOP INTEND. Eleven similarly aged children, who were investigated to rule out neurological or infectious disease, were used as controls. Baseline levels of NFL (4598 ± 981 vs 148 ± 39, P = 0.001), tau (939 ± 159 vs 404 ± 86, P = 0.02), and GFAP (236 ± 44 vs 108 ± 26, P = 0.02) were significantly higher in SMA children than controls. Motor function improved by nusinersen treatment in median 13 points corresponding to 5.4 points per month of treatment (P = 0.001). NFL levels typically normalized ( < 380 pg/ml) between the fourth and fifth doses [− 879.5 pg/mL/dose, 95% CI (− 1243.4, − 415.6), P = 0.0001], tau levels decreased [− 112.6 pg/mL/dose, 95% CI (− 206–7, − 18.6), P = 0.01], and minor decreases in GFAP were observed [− 16.9 pg/mL/dose, 95% CI (− 22.8, − 11.2), P = 0.02] by nusinersen treatment. Improvement in motor function correlated with reduced concentrations of NFL (rho = − 0.64, P = 0.03) and tau (rho = − 0.85, P = 0.0008) but not GFAP. Nusinersen normalized the axonal damage marker NFL and correlated with motor improvement in children with SMA. NFL may, therefore, be a novel biomarker to monitor treatment response early in the disease course.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 8,170,536 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

treatment, sma, nfl, children, nusinersen, motor, levels, csf, article, tau, disease, age, function, study, dose, google, scholar, change, baseline, gfap, cas, pubmed, biomarker, smn, chop, intend, onset, clinical, patient, zetterberg, spinal, type, patients, marker, treated, points, protein, hospital, university, analysis, access, muscular, atrophy, effects, increased, received, olsson, blennow, gene, included,

Topics {✒️}

amyotrophic lateral sclerosis long-term rescue anna-karin kroksmark report enzyme-linked immunosorbent assays article download pdf anti-sense oligonucleotide drug spinal muscular atrophy board-certified laboratory technicians neuron-specific structural proteins lisa wahlgren & már tulinius anna-karin kroksmark cerebrospinal fluid biomarkers consecutive single-center study related subjects sma-determining gene smn clinical cerebrospinal fluid single-nucleotide base change privacy choices/manage cookies clinical neurochemistry laboratory full access queen silvia children neurofilament light protein european research council brain biomarkers solutions clinical laboratory practice swedish research council pediatric neuroinflammatory disorders swedish state support including transient headache chop intend score mixed effects modelling nf-light kit article olsson separate interaction terms cerebrospinal fluid single-center study european economic area require wheelchair assistance heavy counterpart makes intermediate axonal filaments determine axonal caliber part axonal velocity intermediate filament present facial nerve palsy regional ethics committee innotest htau kit statistical significance threshold benign medical history opsoclonus–myoclonus syndrome de vivo dc

Schema {🗺️}

WebPage:
      mainEntity:
         headline:NFL is a marker of treatment response in children with SMA treated with nusinersen
         description:Recently, the anti-sense oligonucleotide drug nusinersen was approved for spinal muscular atrophy (SMA) and our aim was to find a response marker for this treatment. Twelve children with SMA type 1 and two copies of the SMN2 gene were included in a consecutive single-center study. The children were sampled for CSF at baseline and every time nusinersen was given intrathecally. The neuronal biomarkers NFL and tau and the glial biomarker GFAP were measured. Motor function was assessed using CHOP INTEND. Eleven similarly aged children, who were investigated to rule out neurological or infectious disease, were used as controls. Baseline levels of NFL (4598 ± 981 vs 148 ± 39, P = 0.001), tau (939 ± 159 vs 404 ± 86, P = 0.02), and GFAP (236 ± 44 vs 108 ± 26, P = 0.02) were significantly higher in SMA children than controls. Motor function improved by nusinersen treatment in median 13 points corresponding to 5.4 points per month of treatment (P = 0.001). NFL levels typically normalized ( < 380 pg/ml) between the fourth and fifth doses [− 879.5 pg/mL/dose, 95% CI (− 1243.4, − 415.6), P = 0.0001], tau levels decreased [− 112.6 pg/mL/dose, 95% CI (− 206–7, − 18.6), P = 0.01], and minor decreases in GFAP were observed [− 16.9 pg/mL/dose, 95% CI (− 22.8, − 11.2), P = 0.02] by nusinersen treatment. Improvement in motor function correlated with reduced concentrations of NFL (rho = − 0.64, P = 0.03) and tau (rho = − 0.85, P = 0.0008) but not GFAP. Nusinersen normalized the axonal damage marker NFL and correlated with motor improvement in children with SMA. NFL may, therefore, be a novel biomarker to monitor treatment response early in the disease course.
         datePublished:2019-05-23T00:00:00Z
         dateModified:2019-05-23T00:00:00Z
         pageStart:2129
         pageEnd:2136
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s00415-019-09389-8
         keywords:
            SMA
            Cerebrospinal fluid
            Biomarkers
            Neurofilament
            Tau
            Neurology
            Neurosciences
            Neuroradiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00415-019-09389-8/MediaObjects/415_2019_9389_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00415-019-09389-8/MediaObjects/415_2019_9389_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00415-019-09389-8/MediaObjects/415_2019_9389_Fig3_HTML.png
         isPartOf:
            name:Journal of Neurology
            issn:
               1432-1459
               0340-5354
            volumeNumber:266
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Bob Olsson
               affiliation:
                     name:Sahlgrenska Academy at the University of Gothenburg
                     address:
                        name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Sahlgrenska University Hospital
                     address:
                        name:Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Lars Alberg
               affiliation:
                     name:Sahlgrenska University Hospital
                     address:
                        name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nicholas C. Cullen
               affiliation:
                     name:Sahlgrenska Academy at the University of Gothenburg
                     address:
                        name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
                        type:PostalAddress
                     type:Organization
                     name:University of Pennsylvania
                     address:
                        name:Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eva Michael
               affiliation:
                     name:Sahlgrenska University Hospital
                     address:
                        name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Sahlgrenska Academy at the University of Gothenburg
                     address:
                        name:Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lisa Wahlgren
               affiliation:
                     name:Sahlgrenska University Hospital
                     address:
                        name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Sahlgrenska Academy at the University of Gothenburg
                     address:
                        name:Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anna-Karin Kroksmark
               affiliation:
                     name:Sahlgrenska University Hospital
                     address:
                        name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Sahlgrenska Academy at the University of Gothenburg
                     address:
                        name:Institute of Health and Care Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburgs, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kevin Rostasy
               affiliation:
                     name:Witten/Herdecke University
                     address:
                        name:Pediatric Neurology, Children’S Hospital Datteln, Witten/Herdecke University, Datteln, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kaj Blennow
               affiliation:
                     name:Sahlgrenska Academy at the University of Gothenburg
                     address:
                        name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Sahlgrenska University Hospital
                     address:
                        name:Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Henrik Zetterberg
               affiliation:
                     name:Sahlgrenska Academy at the University of Gothenburg
                     address:
                        name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Sahlgrenska University Hospital
                     address:
                        name:Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
                        type:PostalAddress
                     type:Organization
                     name:UCL Institute of Neurology, Queen Square
                     address:
                        name:Department of Neurodegeneration, UCL Institute of Neurology, Queen Square, London, UK
                        type:PostalAddress
                     type:Organization
                     name:UK Dementia Research Institute at UCL
                     address:
                        name:UK Dementia Research Institute at UCL, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Már Tulinius
               affiliation:
                     name:Sahlgrenska University Hospital
                     address:
                        name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Sahlgrenska Academy at the University of Gothenburg
                     address:
                        name:Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:NFL is a marker of treatment response in children with SMA treated with nusinersen
      description:Recently, the anti-sense oligonucleotide drug nusinersen was approved for spinal muscular atrophy (SMA) and our aim was to find a response marker for this treatment. Twelve children with SMA type 1 and two copies of the SMN2 gene were included in a consecutive single-center study. The children were sampled for CSF at baseline and every time nusinersen was given intrathecally. The neuronal biomarkers NFL and tau and the glial biomarker GFAP were measured. Motor function was assessed using CHOP INTEND. Eleven similarly aged children, who were investigated to rule out neurological or infectious disease, were used as controls. Baseline levels of NFL (4598 ± 981 vs 148 ± 39, P = 0.001), tau (939 ± 159 vs 404 ± 86, P = 0.02), and GFAP (236 ± 44 vs 108 ± 26, P = 0.02) were significantly higher in SMA children than controls. Motor function improved by nusinersen treatment in median 13 points corresponding to 5.4 points per month of treatment (P = 0.001). NFL levels typically normalized ( < 380 pg/ml) between the fourth and fifth doses [− 879.5 pg/mL/dose, 95% CI (− 1243.4, − 415.6), P = 0.0001], tau levels decreased [− 112.6 pg/mL/dose, 95% CI (− 206–7, − 18.6), P = 0.01], and minor decreases in GFAP were observed [− 16.9 pg/mL/dose, 95% CI (− 22.8, − 11.2), P = 0.02] by nusinersen treatment. Improvement in motor function correlated with reduced concentrations of NFL (rho = − 0.64, P = 0.03) and tau (rho = − 0.85, P = 0.0008) but not GFAP. Nusinersen normalized the axonal damage marker NFL and correlated with motor improvement in children with SMA. NFL may, therefore, be a novel biomarker to monitor treatment response early in the disease course.
      datePublished:2019-05-23T00:00:00Z
      dateModified:2019-05-23T00:00:00Z
      pageStart:2129
      pageEnd:2136
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s00415-019-09389-8
      keywords:
         SMA
         Cerebrospinal fluid
         Biomarkers
         Neurofilament
         Tau
         Neurology
         Neurosciences
         Neuroradiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00415-019-09389-8/MediaObjects/415_2019_9389_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00415-019-09389-8/MediaObjects/415_2019_9389_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00415-019-09389-8/MediaObjects/415_2019_9389_Fig3_HTML.png
      isPartOf:
         name:Journal of Neurology
         issn:
            1432-1459
            0340-5354
         volumeNumber:266
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Bob Olsson
            affiliation:
                  name:Sahlgrenska Academy at the University of Gothenburg
                  address:
                     name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Sahlgrenska University Hospital
                  address:
                     name:Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Lars Alberg
            affiliation:
                  name:Sahlgrenska University Hospital
                  address:
                     name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nicholas C. Cullen
            affiliation:
                  name:Sahlgrenska Academy at the University of Gothenburg
                  address:
                     name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
                     type:PostalAddress
                  type:Organization
                  name:University of Pennsylvania
                  address:
                     name:Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eva Michael
            affiliation:
                  name:Sahlgrenska University Hospital
                  address:
                     name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Sahlgrenska Academy at the University of Gothenburg
                  address:
                     name:Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lisa Wahlgren
            affiliation:
                  name:Sahlgrenska University Hospital
                  address:
                     name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Sahlgrenska Academy at the University of Gothenburg
                  address:
                     name:Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anna-Karin Kroksmark
            affiliation:
                  name:Sahlgrenska University Hospital
                  address:
                     name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Sahlgrenska Academy at the University of Gothenburg
                  address:
                     name:Institute of Health and Care Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburgs, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kevin Rostasy
            affiliation:
                  name:Witten/Herdecke University
                  address:
                     name:Pediatric Neurology, Children’S Hospital Datteln, Witten/Herdecke University, Datteln, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kaj Blennow
            affiliation:
                  name:Sahlgrenska Academy at the University of Gothenburg
                  address:
                     name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Sahlgrenska University Hospital
                  address:
                     name:Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Henrik Zetterberg
            affiliation:
                  name:Sahlgrenska Academy at the University of Gothenburg
                  address:
                     name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Sahlgrenska University Hospital
                  address:
                     name:Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
                     type:PostalAddress
                  type:Organization
                  name:UCL Institute of Neurology, Queen Square
                  address:
                     name:Department of Neurodegeneration, UCL Institute of Neurology, Queen Square, London, UK
                     type:PostalAddress
                  type:Organization
                  name:UK Dementia Research Institute at UCL
                  address:
                     name:UK Dementia Research Institute at UCL, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Már Tulinius
            affiliation:
                  name:Sahlgrenska University Hospital
                  address:
                     name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Sahlgrenska Academy at the University of Gothenburg
                  address:
                     name:Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Neurology
      issn:
         1432-1459
         0340-5354
      volumeNumber:266
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Sahlgrenska Academy at the University of Gothenburg
      address:
         name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
         type:PostalAddress
      name:Sahlgrenska University Hospital
      address:
         name:Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
         type:PostalAddress
      name:Sahlgrenska University Hospital
      address:
         name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
         type:PostalAddress
      name:Sahlgrenska Academy at the University of Gothenburg
      address:
         name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
         type:PostalAddress
      name:University of Pennsylvania
      address:
         name:Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
         type:PostalAddress
      name:Sahlgrenska University Hospital
      address:
         name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
         type:PostalAddress
      name:Sahlgrenska Academy at the University of Gothenburg
      address:
         name:Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
         type:PostalAddress
      name:Sahlgrenska University Hospital
      address:
         name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
         type:PostalAddress
      name:Sahlgrenska Academy at the University of Gothenburg
      address:
         name:Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
         type:PostalAddress
      name:Sahlgrenska University Hospital
      address:
         name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
         type:PostalAddress
      name:Sahlgrenska Academy at the University of Gothenburg
      address:
         name:Institute of Health and Care Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburgs, Sweden
         type:PostalAddress
      name:Witten/Herdecke University
      address:
         name:Pediatric Neurology, Children’S Hospital Datteln, Witten/Herdecke University, Datteln, Germany
         type:PostalAddress
      name:Sahlgrenska Academy at the University of Gothenburg
      address:
         name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
         type:PostalAddress
      name:Sahlgrenska University Hospital
      address:
         name:Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
         type:PostalAddress
      name:Sahlgrenska Academy at the University of Gothenburg
      address:
         name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
         type:PostalAddress
      name:Sahlgrenska University Hospital
      address:
         name:Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
         type:PostalAddress
      name:UCL Institute of Neurology, Queen Square
      address:
         name:Department of Neurodegeneration, UCL Institute of Neurology, Queen Square, London, UK
         type:PostalAddress
      name:UK Dementia Research Institute at UCL
      address:
         name:UK Dementia Research Institute at UCL, London, UK
         type:PostalAddress
      name:Sahlgrenska University Hospital
      address:
         name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
         type:PostalAddress
      name:Sahlgrenska Academy at the University of Gothenburg
      address:
         name:Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Bob Olsson
      affiliation:
            name:Sahlgrenska Academy at the University of Gothenburg
            address:
               name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
               type:PostalAddress
            type:Organization
            name:Sahlgrenska University Hospital
            address:
               name:Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Lars Alberg
      affiliation:
            name:Sahlgrenska University Hospital
            address:
               name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
               type:PostalAddress
            type:Organization
      name:Nicholas C. Cullen
      affiliation:
            name:Sahlgrenska Academy at the University of Gothenburg
            address:
               name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
               type:PostalAddress
            type:Organization
            name:University of Pennsylvania
            address:
               name:Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:Eva Michael
      affiliation:
            name:Sahlgrenska University Hospital
            address:
               name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
               type:PostalAddress
            type:Organization
            name:Sahlgrenska Academy at the University of Gothenburg
            address:
               name:Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
               type:PostalAddress
            type:Organization
      name:Lisa Wahlgren
      affiliation:
            name:Sahlgrenska University Hospital
            address:
               name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
               type:PostalAddress
            type:Organization
            name:Sahlgrenska Academy at the University of Gothenburg
            address:
               name:Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
               type:PostalAddress
            type:Organization
      name:Anna-Karin Kroksmark
      affiliation:
            name:Sahlgrenska University Hospital
            address:
               name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
               type:PostalAddress
            type:Organization
            name:Sahlgrenska Academy at the University of Gothenburg
            address:
               name:Institute of Health and Care Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburgs, Sweden
               type:PostalAddress
            type:Organization
      name:Kevin Rostasy
      affiliation:
            name:Witten/Herdecke University
            address:
               name:Pediatric Neurology, Children’S Hospital Datteln, Witten/Herdecke University, Datteln, Germany
               type:PostalAddress
            type:Organization
      name:Kaj Blennow
      affiliation:
            name:Sahlgrenska Academy at the University of Gothenburg
            address:
               name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
               type:PostalAddress
            type:Organization
            name:Sahlgrenska University Hospital
            address:
               name:Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
               type:PostalAddress
            type:Organization
      name:Henrik Zetterberg
      affiliation:
            name:Sahlgrenska Academy at the University of Gothenburg
            address:
               name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
               type:PostalAddress
            type:Organization
            name:Sahlgrenska University Hospital
            address:
               name:Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
               type:PostalAddress
            type:Organization
            name:UCL Institute of Neurology, Queen Square
            address:
               name:Department of Neurodegeneration, UCL Institute of Neurology, Queen Square, London, UK
               type:PostalAddress
            type:Organization
            name:UK Dementia Research Institute at UCL
            address:
               name:UK Dementia Research Institute at UCL, London, UK
               type:PostalAddress
            type:Organization
      name:Már Tulinius
      affiliation:
            name:Sahlgrenska University Hospital
            address:
               name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
               type:PostalAddress
            type:Organization
            name:Sahlgrenska Academy at the University of Gothenburg
            address:
               name:Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
      name:Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
      name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
      name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
      name:Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
      name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
      name:Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
      name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
      name:Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
      name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
      name:Institute of Health and Care Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburgs, Sweden
      name:Pediatric Neurology, Children’S Hospital Datteln, Witten/Herdecke University, Datteln, Germany
      name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
      name:Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
      name:Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
      name:Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
      name:Department of Neurodegeneration, UCL Institute of Neurology, Queen Square, London, UK
      name:UK Dementia Research Institute at UCL, London, UK
      name:Queen Silvia Children’S Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
      name:Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden

External Links {🔗}(100)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.75s.